Executive Director, Value & Access Strategy

Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description:

The Executive Director of Value and Access reports to the Vice President Market Access, Pricing and Distribution. This strategic leader manages a team of Directors who will be responsible for pricing and contracting, patient support services, and market access payer marketing. This Executive Director provides strategic leadership to maximize access and profitability of Replimune brands across all market access segments. This role drives the payer marketing strategy, product value proposition and leads the development and execution of tactical plans to support commercial launch activities. This leader will finalize launch metrics, establish patient services capabilities and directs both the internal and external access disease education strategy.

Key responsibilities:

· Integrate market access developments, value insights, and payer perspectives into actionable brand launch and lifecycle management plans.

· Provide strategic leadership to ensure payer marketplace evolution, value insights and payer perspectives are integrated and activated into strategic plans across brand launch and life cycle management objectives.

· Functions as primary resource to assess and evaluate US and ex-US macro trends in the healthcare environment that potentially impact current and/or future product pricing, contracting and associated strategies.

· Execute US value-based pricing strategies, net-revenue optimizations, and contract/discount frameworks, if needed, while improving the patient and customer experience

· Lead international pricing assessments and strategy development for ex-US commercial markets.

·

· Lead interface with Finance to develop forecasting and revenue recognition models for evaluation of WAC/NET/GTN.

· Build engagement strategies to inform and prepare the market both pre and post launch to deliver the brand value proposition to ensure patient access.

· Conduct market research and tactic creation in partnership with the Brand team to communicate strategic imperatives and optimize value of products.

· Collaborate in the development of market access data requirements and KPI evaluation.

· Lead assessment, development and implementation of patient support service capabilities.

· In conjunction with Medical and HEOR teams, work to develop long-range strategies and tactics to understand the evolution of payer evidence needs.

· Collaborate with Payer and Reimbursement lead to develop and advance field content requirements.

· Lead and execute product and procedure reimbursement coding initiatives to ensure access for product portfolio

· Develop, revise and maintain assigned branded and non-branded account management resources to facilitate and accelerate access and brand growth.

· Recruit, develop and retain a high performing team and establish a results-driven, customer-focused and team-centered culture.

· Develop and manage operational budgets consistent with corporate financial goals.

· Ensure compliance with corporate policies and procedures, as well as US Healthcare laws and regulations.

Other responsibilities:

· Willing to undertake various responsibilities outside of your area of expertise as opportunity presents.

Educational requirements:

College degree with MBA preferred.

Experience and skill requirement:

· 10+ years of relevant pharmaceutical/biotech experience, including a proven track record of managing a team of high-performing leaders.

· Comprehensive knowledge of US healthcare systems, reimbursement challenges, and commercial opportunities.

· Demonstrated experience developing pricing, commercialization, and access strategies for both US and international ex-US markets.

· Proven understanding of coding and billing requirements, including the formal coding application process.

· In-depth functional proficiency across market access, pricing and contracting, life cycle management, and patient services.

· Strong proficiency in financial analytics, P&L management, and commercial forecast development.

· Customer-centric approach focused on creating sustainable and scalable access solutions.

· Deep understanding of the commercialization process, reimbursement integration points, and clinical development workflows.

· Direct US experience with product launch execution, commercial sales/marketing, and pricing architecture.

· Ability to travel as required to meet business demands.

Salary Range

Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $279,000-361,000. The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer.

At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown.

About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit .

We are an Equal Opportunity Employer.